Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
6.55
-0.12 (-1.80%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Valneva SE Market Cap
Valneva SE has a market cap or net worth of $617.63 million as of September 15, 2026. Its market cap has decreased by -19.32% in one year.
Market Cap
617.63M
Enterprise Value
720.04M
1-Year Change
-19.32%
Ranking
Category
Stock Price
$6.55
ChartMarket Cap Chart
Since the IPO on May 6, 2021, Valneva SE's market cap has decreased from $1.29B to $617.63M, a decrease of -52.22%. That is a compound annual growth rate of -12.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 617.63M | -18.10% |
| Dec 31, 2025 | 754.16M | 107.47% |
| Dec 31, 2024 | 363.50M | -49.80% |
| Dec 29, 2023 | 724.08M | -21.32% |
| Dec 30, 2022 | 920.30M | -68.57% |
| Dec 31, 2021 | 2.93B | 126.51% |
| May 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sagimet Biosciences | 650.18M |
| Phathom Pharmaceuticals | 648.15M |
| OmniAb | 632.45M |
| Altimmune | 628.29M |
| Oculis Holding AG | 621.64M |
| CorMedix | 604.85M |
| AgomAb Therapeutics NV | 601.81M |
| Scribe Therapeutics | 599.38M |